Liver Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Feb 15, 2002; 8(1): 82-86
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.82
Figure 3
Figure 3 Focal nodular hyperplasia(FNH). Before enhancement, the lesion (arrow) presents hypointensity on T1WI and heterogeneous hyerintensity on T2WI (A). After Gd-DTPA administration, the lesion is obviously en-hanced in arterial phase and remains hyperintense in portal and delayed phase (B). On T2WI after SPIO enhancement, the lesion(arrow) has focal signal loss compared with the un-enhanced image (C).